Deutsche Bank Ag\ Bio Xcel Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.32 - $5.51 $34,969 - $83,052	15,073 Added 611.73%	17,537 $51,000
Q3 2023 Nov 09, 2023	SELL	$2.49 - $11.85 $27,589 - $131,298	-11,080 Reduced 81.81%	2,464 $6,000
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $90,233 - $403,578	-14,121 Reduced 51.04%	13,544 $90,000
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $61,843 - $116,140	3,494 Added 14.46%	27,665 $516,000
Q4 2022 Feb 13, 2023	SELL	$10.25 - $22.43 $11,141 - $24,381	-1,087 Reduced 4.3%	24,171 $519,000
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $18,105 - $28,946	-1,618 Reduced 6.02%	25,258 $298,000
Q2 2022 Aug 11, 2022	BUY	$9.03 - $21.55 $20,290 - $48,422	2,247 Added 9.12%	26,876 $354,000
Q1 2022 May 13, 2022	SELL	$15.0 - $22.83 $59,970 - $91,274	-3,998 Reduced 13.97%	24,629 $514,000
Q4 2021 Feb 11, 2022	SELL	$20.12 - $35.09 $85,852 - $149,729	-4,267 Reduced 12.97%	28,627 $582,000
Q3 2021 Nov 04, 2021	BUY	$23.84 - $32.03 $206,692 - $277,700	8,670 Added 35.79%	32,894 $999,000
Q2 2021 Aug 11, 2021	BUY	$29.06 - $38.83 $11,304 - $15,104	389 Added 1.63%	24,224 $704,000
Q1 2021 May 13, 2021	SELL	$39.04 - $64.6 $35,096 - $58,075	-899 Reduced 3.63%	23,835 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $178,968 - $238,484	4,215 Added 20.54%	24,734 $1.14 Million
Q3 2020 Nov 12, 2020	BUY	$37.44 - $64.63 $47,249 - $81,563	1,262 Added 6.55%	20,519 $890,000
Q2 2020 Aug 13, 2020	BUY	$17.62 - $58.71 $64,119 - $213,645	3,639 Added 23.3%	19,257 $1.02 Million
Q1 2020 May 14, 2020	SELL	$12.26 - $41.14 $294 - $987	-24 Reduced 0.15%	15,618 $349,000
Q4 2019 Feb 14, 2020	BUY	$4.05 - $14.61 $56,469 - $203,707	13,943 Added 820.66%	15,642 $227,000
Q3 2019 Nov 14, 2019	SELL	$7.04 - $11.77 $20,014 - $33,462	-2,843 Reduced 62.59%	1,699 $10,000
Q2 2019 Aug 14, 2019	BUY	$8.99 - $11.79 $40,832 - $53,550	4,542 New	4,542 $49,000
Q1 2019 May 15, 2019	SELL	$3.49 - $10.47 $17,959 - $53,878	-5,146 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.41 - $7.61 $4,930 - $15,570	2,046 Added 66.0%	5,146 $19,000
Q3 2018 Nov 14, 2018	BUY	$7.51 - $12.99 $23,281 - $40,269	3,100 New	3,100 $23,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account